```html

Yellow Plaque on Skin (Xanthomas)

What is Yellow plaque on skin (xanthomas)?

Xanthomas are firm, yellow‑orange plaques or nodules that develop within the dermis (the deeper layer of skin). They are composed of clusters of lipid‑laden macrophages, called foam cells, that accumulate when blood lipids (fats) are abnormally high or when certain metabolic disorders alter lipid storage. Though the word “plaque” suggests a flat lesion, xanthomas can range from flat, spread‑out patches to raised nodules that feel rubbery or slightly gritty to the touch.

Because they are a visible clue that the body’s lipid metabolism is out of balance, xanthomas often prompt a deeper medical work‑up to uncover underlying conditions such as high cholesterol, diabetes, or rare genetic disorders. The appearance, location, and size of the plaques can give clinicians valuable hints about the specific cause.

Key points

• Yellow‑orange color results from accumulated cholesterol and triglycerides.
• Most commonly appear on elbows, knees, hands, feet, buttocks, and eyelids.
• Not contagious; they are a manifestation of internal metabolic changes.

Common Causes

Below are the most frequently encountered conditions that can produce xanthomas. The list includes both common metabolic disorders and rarer genetic diseases.

• Hyperlipidemia (familial or secondary) – Elevated LDL‑cholesterol or triglycerides, often due to genetic mutations (e.g., LDLR, APOB) or lifestyle factors.
• Primary biliary cholangitis – Chronic liver disease that impairs bile excretion, leading to cholesterol buildup.
• Type 2 Diabetes Mellitus – Associated with dyslipidemia and insulin resistance, which can cause eruptive xanthomas.
• Familial hypercholesterolemia (FH) – An autosomal‑dominant disorder causing very high LDL‑C from birth.
• Drug‑induced lipid disturbances – Medications such as isotretinoin, cyclosporine, or protease inhibitors may raise triglycerides.
• Hepatitis C infection – Can cause mixed cryoglobulinemia with cutaneous manifestations, including xanthomas.
• Lipoprotein (a) excess – Elevated Lp(a) is a risk factor for cardiovascular disease and may present with tuberous xanthomas.
• Gaucher disease (type 1) – A lysosomal storage disorder producing “crème caramel” colored plaques.
• Necrobiosis lipoidica – Often linked with diabetes; lesions are yellow‑brown with a central atrophy.
• Cholesterol ester storage disease – Rare genetic defect in ACAT2 enzyme leading to systemic lipid accumulation.

Associated Symptoms

While many individuals notice only the skin changes, xanthomas frequently coexist with other signs that reflect the underlying metabolic problem.

• Fatigue or weakness – Common in uncontrolled diabetes or liver disease.
• Chest pain or shortness of breath – May indicate atherosclerotic cardiovascular disease, especially in FH.
• Abdominal pain, hepatomegaly, or jaundice – Signs of liver dysfunction (e.g., primary biliary cholangitis).
• Peripheral neuropathy or tingling – Can accompany diabetes.
• Joint pain or swelling – Seen in some lysosomal storage disorders.
• Eye changes (e.g., corneal arcus) – Another lipid‑related manifestation.

When to See a Doctor

Any new yellow plaque warrants medical attention, but watch for the following warning signs that require prompt evaluation:

• Rapid growth or sudden appearance of multiple plaques.
• Pain, tenderness, or ulceration of the lesion.
• Associated chest discomfort, palpitations, or shortness of breath.
• Signs of liver disease: jaundice, dark urine, swelling of the abdomen.
• Unexplained weight loss, fever, or night sweats.
• Family history of early heart attacks or known lipid disorders.

Early assessment can identify treatable lipid abnormalities and reduce the risk of serious cardiovascular events.

Diagnosis

Diagnosing xanthomas involves a combination of visual examination, laboratory testing, and sometimes imaging.

1. Clinical Examination

• Dermatologic inspection – description of size, shape, distribution, and texture.
• Palpation – assessing firmness and tenderness.
• Review of medical and family history for lipid disorders.

2. Laboratory Tests

• Lipid panel – Total cholesterol, LDL‑C, HDL‑C, triglycerides.
• Lipoprotein(a) and apolipoprotein B – Helpful in familial cases.
• Fasting glucose and HbA1c – Screen for diabetes.
• Liver function tests (ALT, AST, ALP, GGT, bilirubin) – Detect hepatic disease.
• Thyroid function tests – Hypothyroidism can raise cholesterol.
• Genetic testing (e.g., LDLR, APOB, PCSK9) – Confirm familial hypercholesterolemia.

3. Imaging & Other Tests

• Ultrasound or CT angiography – Assess for atherosclerotic plaque if cardiovascular risk is high.
• Skin biopsy – Rarely needed; histology shows foam cells and cholesterol clefts.
• Fundoscopic exam – Look for corneal arcus, another lipid sign.

4. Differential Diagnosis

Conditions that can mimic xanthomas include:

• Dermatitis neglecta
• Granuloma annulare
• Necrobiosis lipoidica
• Psoriasis (especially when yellow scaling is present)

Treatment Options

Management targets both the skin lesions and the underlying metabolic abnormality.

1. Lifestyle Modification

• Diet – Emphasize a heart‑healthy Mediterranean diet: lots of vegetables, fruits, whole grains, fish, nuts, and olive oil; limit saturated fat, trans fat, and simple sugars.
• Physical activity – At least 150 minutes of moderate‑intensity aerobic exercise per week.
• Weight management – Achieving a BMI < 25 kg/m² often improves lipid levels.
• Alcohol moderation – Excess intake raises triglycerides.

2. Pharmacologic Therapy

• Statins (e.g., atorvastatin, rosuvastatin) – First‑line for LDL‑C reduction; can cause regression of tendinous and eruptive xanthomas within months.
• Ezetimibe – Blocks intestinal cholesterol absorption; useful when statins alone are insufficient.
• PCSK9 inhibitors (evolocumab, alirocumab) – Powerful LDL‑C reducers for familial hypercholesterolemia or statin‑intolerant patients.
• Fibrates (gemfibrozil, fenofibrate) – Lower triglycerides; especially effective for eruptive xanthomas.
• Niacin – Raises HDL‑C and lowers LDL‑C/triglycerides, but side effects limit use.
• Omega‑3 fatty acid supplements – Helpful for severe hypertriglyceridemia.

3. Direct Lesion Treatments

• Laser therapy – Pulsed dye or CO₂ lasers can reduce the appearance of superficial plaques.
• Surgical excision – Considered for large, nodular xanthomas that cause functional impairment.
• Cryotherapy – Occasionally used for small eruptive lesions.

4. Monitoring

Regardless of treatment, lipid levels should be re‑checked every 3–6 months until stable, then annually. Patients with genetic lipid disorders often require lifelong therapy and periodic cardiovascular imaging.

Prevention Tips

While not all causes are preventable (e.g., inherited FH), many lifestyle‑related risk factors can be modified.

• Adopt a heart‑healthy diet low in saturated fat and refined carbohydrates.
• Maintain regular physical activity—aim for at least 30 minutes most days.
• Keep an eye on weight; obesity worsens dyslipidemia.
• Avoid smoking and limit alcohol consumption.
• Screen family members if a genetic lipid disorder is diagnosed.
• Get routine lipid panels as recommended by your physician, especially after the age of 20 or earlier if there is a family history.

Emergency Warning Signs

If any of the following occur, seek emergency medical care (call 911 or go to the nearest emergency department):

• Sudden, severe chest pain or pressure radiating to the arm, jaw, or back.
• Shortness of breath that is new or worsening.
• Rapid onset of neurological symptoms (weakness, slurred speech, vision loss).
• Acute abdominal pain with vomiting, especially if accompanied by jaundice.
• Rapid swelling, redness, or warmth around a xanthoma suggesting infection.

References

1. Mayo Clinic. “Xanthomas.” https://www.mayoclinic.org. Accessed April 2026.
2. National Heart, Lung, & Blood Institute. “High Blood Cholesterol.” https://www.nhlbi.nih.gov. Accessed April 2026.
3. American Diabetes Association. “Standards of Care in Diabetes—2024.” Diabetes Care. 2024;47(Suppl 1):S1‑S350.
4. World Health Organization. “Global Recommendations on Physical Activity for Health.” 2020. https://www.who.int.
5. Cleveland Clinic. “Familial Hypercholesterolemia.” https://my.clevelandclinic.org. Accessed April 2026.
6. NIH National Institute of Diabetes and Digestive and Kidney Diseases. “Gaucher Disease.” https://www.niddk.nih.gov. Accessed April 2026.
7. J. Freund et al., “Eruptive Xanthomas as a Marker of Severe Hypertriglyceridemia,” *Journal of Clinical Lipidology*, 2022;16(4):467‑475.

```